Home ›
Entities
› academia
› Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare.
Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare.
Research article (Archives of Medical Science, 2022) · cited 17× · AI/ML
Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare.
Summary
Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare. is a scholarly article[1].
Key Facts
Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare.'s instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare.. Retrieved May 24, 2026, from https://4ort.xyz/entity/which-patients-at-risk-of-cardiovascular-disease-might-benefit-the-most-from-inclisiran-the-expert-opinion-of-the-polish
MLA“Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare..” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/which-patients-at-risk-of-cardiovascular-disease-might-benefit-the-most-from-inclisiran-the-expert-opinion-of-the-polish.
BibTeX@misc{4ortxyz_which-patients-at-risk-of-cardiovascular-disease-might-benefit-the-most-from-inclisiran-the-expert-opinion-of-the-polish_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare.}}, year = {2026}, url = {https://4ort.xyz/entity/which-patients-at-risk-of-cardiovascular-disease-might-benefit-the-most-from-inclisiran-the-expert-opinion-of-the-polish}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare. — https://4ort.xyz/entity/which-patients-at-risk-of-cardiovascular-disease-might-benefit-the-most-from-inclisiran-the-expert-opinion-of-the-polish (retrieved 2026-05-24)
